Abstract:The retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), including RIG-I and melanoma differentiation-associated gene 5 (MDA5), sense cytoplasmic viral RNA and initiate innate antiviral responses. How RIG-I and MDA5 are differentially regulated remains enigmatic. In this study, we identified the guanylate-binding protein (GBP) and zinc-finger FYVE domain-containing protein ZFYVE1 as a negative regulator of MDA5- but not RIG-I-mediated innate antiviral responses. ZFYVE1-deficiency promoted MDA5- but not RIG-I-mediated transcription of downstream antiviral genes. Comparing to wild-type mice, Zfyve1(-/-) mice were significantly protected from lethality induced by encephalomyocarditis virus (EMCV) that is sensed by MDA5, whereas Zfyve1(-/-) and Zfyve1(+/+) mice were comparable to death induced by vesicular stomatitis virus (VSV) that is sensed by RIG-I. Mechanistically, ZFYVE1 interacted with MDA5 but not RIG-I. ZFYVE1 bound to viral RNA and decreased the ligand binding and oligomerization of MDA5. These findings suggest that ZFYVE1 acts as a specific negative regulator of MDA5-mediated innate immune responses by inhibiting its ligand binding and oligomerization. Author summary RIG-I and MDA5 are the main cytosolic sensors for invaded viral RNA. How these sensors are differentially regulated is largely unknown. In this study, we identified ZFYVE1 as a specific regulator of MDA5- but not RIG-I-mediated antiviral responses. ZFYVE1-deficiency promotes antiviral immune responses and renders the mice less susceptible to EMCV-induced death. ZFYVE1 interacts with MDA5 and viral dsRNA, and inhibits the ligand binding and oligomerization of MDA5. Our study reveals a negative regulatory mechanism for keeping MDA5 inactive in un-infected cells, which contributes to our understanding on how innate antiviral responses are delicately regulated to avoid immune damage.

RNF144B negatively regulates antiviral immunity by targeting MDA5 for autophagic degradation

NBR1 Mediates Autophagic Degradation of IRF3 to Negatively Regulate Type I Interferon Production.

Negative Regulation of RNF90 on RNA Virus-Triggered Antiviral Immune Responses Targeting MAVS

RNF115 plays dual roles in innate antiviral responses by catalyzing distinct ubiquitination of MAVS and MITA

RNF123 has an E3 ligase-independent function in RIG-I-like receptor-mediated antiviral signaling

RNF90 negatively regulates cellular antiviral responses by targeting MITA for degradation

ZFYVE1 negatively regulates MDA5-but not RIG-I-mediated innate antiviral response

RNF5: inhibiting antiviral immunity and shaping virus life cycle

RAD23A Negatively Regulates RIG-I/MDA5 Signaling Through Promoting TRAF2 Polyubiquitination and Degradation

CD97 Negatively Regulates the Innate Immune Response Against RNA Viruses by Promoting RNF125-mediated RIG-I Degradation.

The Ubiquitin Ligase RNF5 Regulates Antiviral Responses by Mediating Degradation of the Adaptor Protein MITA

ZNF205 positively regulates RLR antiviral signaling by targeting RIG-I

RNF144A promotes antiviral responses by modulating STING ubiquitination

Ring Finger Protein 215 Negatively Regulates Type I IFN Production via Blocking NF-κB p65 Activation.

Downregulated NDR1 Protein Kinase Inhibits Innate Immune Response by Initiating an Mir146a-Stat1 Feedback Loop

Ring Finger Protein 215 Negatively Regulates Type I IFN Production via Blocking NF-KB p65 Activation

Negative Regulation of MDA5- but Not RIG-I-mediated Innate Antiviral Signaling by the Dihydroxyacetone Kinase.

SRP54 Negatively Regulates IFN-Beta Production and Antiviral Response by Targeting RIG-I and MDA5

Trim65-Catalized Ubiquitination is Essential for Mda5-Mediated Antiviral Innate Immunity

LTN1 promotes RLR degradation to inhibit immune response to RNA virus through the ESCRT pathway

NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways